CXCL8 and diabetes mellitus: This review highlights the dual role of neutrophils and NETs in diabetes, elucidates their molecular mechanisms in inflammation and vascular injury, and summarizes emerging therapeutic strategies targeting NETs-such as DNase I, PAD4 inhibitors, and IL-8 blockade-offering new insights for the prevention and treatment of diabetes and its complications.